PICC Group Logs Over 348 Billion Yuan in January-May Premium Income
Insurer PICC Group (HKG:1339, SHA:601319) recorded an original premium income of 348.1 billion yuan as derived from three subsidiaries for the five months ended May 31, a Thursday filing with the Hong
Huize Partners With Picc P&C To Launch Customized Child Outpatient And Emergency Insurance Product; With Optimized Reimbursement, Expanded Coverage And Additional Benefits, The Upgraded Version Delivers Enhanced Cost-effectiveness And Product Value
Huize Partners With Picc P&C To Launch Customized Child Outpatient And Emergency Insurance Product; With Optimized Reimbursement, Expanded Coverage And Additional Benefits, The Upgraded Version Delive
PICC P&C Partners With PICC Technology for Enhanced Services
PICC Group Proposes Auditor Change
PICC Group (HKG:1339, SHA:601319) has proposed the appointment of Ernst & Young Hua Ming and Ernst & Young as auditors for its domestic and international financial statements, respectively, a Wednesda
PICC Property Proposes Extension of Authorization Period for Sale of Capital Supplementary Bonds
PICC Property and Casualty (HKG:2328) will seek shareholders' approval to extend the authorization period for issuing capital supplementary bonds to 24 months. The Chinese insurer cited its failure to
PICC P&C Co Declares Year-End Cash Dividend
PICC Property And Casualty Seek Shareholder Approval for Auditor Change
PICC Property And Casualty Company (HKG:2328) is proposing to hire Ernst & Young as its international auditor and Ernst & Young Hua Ming as its domestic auditor for the year 2024, a Wednesday filing w
PICC P&C to Appoint New Auditors for 2024
PICC P&C Proposes RMB 12 Billion Bond Issuance
PICC Property & Casualty Co Sets AGM for Strategic Decisions
PICC's Total Original Premiums Reach 300 Billion Yuan in First Four Months of 2024
PICC Group (HKG:1339, SHA:601319) logged about 300.1 billion yuan in total original premiums from its property and casualty, life, and health units for the January-April period, according to a Friday
Nomura Adjusts PICC Property and Casualty Company's Price Target at HK$12.15 From HK$12.23, Keeps at Buy
05:42 AM EDT, 04/30/2024 (MT Newswires) -- Nomura Adjusts PICC Property and Casualty Company's Price Target at HK$12.15 From HK$12.23, Keeps at Buy Price (HKD): $9.77, Change: $-0.21, Percent Change:
PICC P&C: Also Affected by Growth in Transportation in 1Q >2328.HK
PICC P&C: Also Affected by Growth in Transportation in 1Q >2328.HK
PICC P&C: Affected by Low Temperature, Rain, Snow, Freezing Weather, Disasters in 1Q >2328.HK
PICC P&C: Affected by Low Temperature, Rain, Snow, Freezing Weather, Disasters in 1Q >2328.HK
PICC Property & Casualty 1Q Net CNY5.87B Vs. Net CNY9.51B >2328.HK
PICC Property & Casualty 1Q Net CNY5.87B Vs. Net CNY9.51B >2328.HK
Nomura Adjusts PICC Property and Casualty's Price Target to HK$12.23 From HK$12.51, Keeps at Buy
05:30 AM EDT, 04/19/2024 (MT Newswires) -- Nomura Adjusts PICC Property and Casualty's Price Target to HK$12.23 From HK$12.51, Keeps at Buy
Huize Partners With PICC Life Insurance to Launch "i Wu You – Low-Threshold Edition" – A Customized Critical Illness Insurance Product
PDF Version SHENZHEN, China, April 19, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, ("Huize", the "Company" or "we") (NASDAQ: HUIZ), a leading insurance technology platform connecting consumer
PICC Group Logs 253 Billion Yuan in Q1 Premium Income
PICC Group (HKG:1339, SHA:601319) recorded an original premium income of 53 billion yuan from its three operating subsidiaries in the first quarter of 2024, according to a Monday filing with the Hong
PICC Property And Casualty Logs Nearly 4% Boost in Q1 Premium Income
PICC Property And Casualty (HKG:2328) recorded an insurance premium income of around 174 billion yuan during the first quarter of 2024, up 3.8% from the year-ago period, a Monday filing on the Hong Ko
Angiodynamic Expects FY2024 Sales Of $270M-$275M, Reflects PICC And Midline Businesses Divestiture And Discontinuance Of RadioFrequency Ablation And Syntrax Businesses, Which Accounted For ~$50M Of Prior Guidance Of $320M-$325M Vs. Consensus Of $312.14M
Angiodynamic Expects FY2024 Sales Of $270M-$275M, Reflects PICC And Midline Businesses Divestiture And Discontinuance Of RadioFrequency Ablation And Syntrax Businesses, Which Accounted For ~$50M Of Pr
No Data